STOCK TITAN

Major PEDEVCO (PED) investor reports 33.1% stake after Series A preferred conversion

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

PEDEVCO Corp’s largest shareholder updated its ownership following a preferred stock conversion. The SGK 2018 Revocable Trust received 28,018,140 common shares on February 27, 2026 when 2,801,814 Series A Preferred shares automatically converted at a 10-for-1 ratio.

After this conversion, the Trust reports beneficial ownership of 79,809,465 common shares, or 30.0% of PEDEVCO’s outstanding stock, while Dr. Simon G. Kukes reports 87,934,415 shares, or 33.1%. The securities are held for investment purposes, and the reporting persons state they may buy or sell additional shares over time but currently have no specific plans for major corporate changes.

Positive

  • None.

Negative

  • None.

Insights

Conversion boosts insider’s common stake to about one‑third of PEDEVCO.

The filing shows Series A Preferred Stock automatically converting into 28,018,140 common shares for The SGK 2018 Revocable Trust on February 27, 2026. This is a non-cash structural change, shifting value from preferred into common equity.

Post-conversion, the Trust reports 30.0% and Dr. Simon G. Kukes 33.1% beneficial ownership of common stock, based on 266,016,298 shares outstanding. Such levels represent significant influence, though the report states the holdings are for investment purposes without concrete plans for mergers, restructurings, or other control transactions.

The disclosure notes that the reporting persons may increase or decrease their stake through market or private transactions. Any future changes in ownership levels or new agreements referenced in this Schedule 13D framework would typically appear in subsequent amendments and could further clarify their strategic intentions.






Dr. Simon G. Kukes
575 N. DAIRY ASHFORD, ENERGY CENTER II, SUITE 210
HOUSTON, TX, 77079
713-221-1768

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
02/27/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
(13) Based on 266,016,298 shares of common stock issued and outstanding as of March 3, 2026, as confirmed by the Company's transfer agent on such date.


SCHEDULE 13D




Comment for Type of Reporting Person:
(8)(10)(11) Includes 3,000 shares of common stock held by Dr. Kukes' spouse. (13) Based on 266,016,298 shares of common stock issued and outstanding as of March 3, 2026, as confirmed by the Company's transfer agent on such date.


SCHEDULE 13D


SGK 2018 REVOCABLE TRUST
Signature:/s/ Dr. Simon G. Kukes
Name/Title:Dr. Simon G. Kukes, Trustee
Date:03/03/2026
KUKES SIMON G
Signature:/s/ Dr. Simon G. Kukes
Name/Title:Dr. Simon G. Kukes
Date:03/03/2026

FAQ

What change in ownership does this PEDEVCO (PED) Schedule 13D/A report?

The Schedule 13D/A reports updated beneficial ownership after a preferred stock conversion. The SGK 2018 Revocable Trust now holds 79,809,465 PEDEVCO common shares (30.0%), and Dr. Simon G. Kukes reports 87,934,415 shares (33.1%) as of 266,016,298 shares outstanding.

How many PEDEVCO shares did the SGK 2018 Revocable Trust receive in the conversion?

The SGK 2018 Revocable Trust received 28,018,140 PEDEVCO common shares. These came from the automatic conversion of 2,801,814 shares of Series A Convertible Preferred Stock at a 10-for-1 ratio on February 27, 2026, following earlier shareholder approval and information statement procedures.

What is Dr. Simon G. Kukes’ total beneficial ownership in PEDEVCO after this amendment?

Dr. Simon G. Kukes reports beneficial ownership of 87,934,415 PEDEVCO common shares, representing 33.1% of the class. This figure includes shares held directly, shares held through The SGK 2018 Revocable Trust, and 3,000 shares of common stock held by his spouse, as disclosed.

Why did PEDEVCO’s Series A Preferred Stock convert into common stock?

The Series A Preferred Stock converted automatically under its terms after a required information statement period. A distribution under Regulation 14C disclosed majority stockholder approval of the conversion and related matters, triggering an automatic conversion date of February 27, 2026 at a 10-for-1 ratio into common shares.

What are the stated intentions of the reporting persons regarding their PEDEVCO holdings?

The reporting persons state they hold PEDEVCO securities for investment purposes. They may buy additional shares or sell some holdings in market or private transactions, but currently disclose no specific plans for mergers, asset sales, board changes, or other major corporate actions beyond what is described.

How was the PEDEVCO ownership percentage calculated in this Schedule 13D/A?

Ownership percentages are based on 266,016,298 PEDEVCO common shares outstanding as of March 3, 2026. The company’s transfer agent confirmed this figure, and the filing uses it to calculate the 30.0% stake for The SGK 2018 Revocable Trust and the 33.1% stake for Dr. Simon G. Kukes.